Third Quarter 2019 report and presentation

Ultimovacs held its presentation of the company’s Q3-19 report on 14 November 2019 at Oslo Cancer Cluster Innovation Park. The presentation was recorded and can be viewed on our webcast

The report and presentation is available in the “Reports and presentation” section.

More information

News

Poster presented on 9 November at the 2019 Annual Meeting of Society for Immunotherapy of Cancer (SITC). The poster is available in the “Reports and Presentations”-section.

News

Technology

Ultimovacs is developing a universal cancer vaccine applicable across a broad spectrum of cancer types.

Technology

Clinical studies

Lead product tested in three clinical trials, strong results justifies the initiation of a registration trial.

Clinical studies